QT
ABBV icon

Quantamental Technologies’s AbbVie ABBV Stock Holding History

Quantamental Technologies’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-10,352
Closed -$1.39M – 289
2023
Q2 		$1.39M Buy
+10,352
New +$1.52M 0.58% 37
2019
Q3 		– Sell
-1,946
Closed -$142K – 1488
2019
Q2 		$142K Sell
1,946
-517
-21% -$40.6K 0.05% 549
2019
Q1 		$198K Sell
2,463
-59
-2% -$4.83K 0.09% 378
2018
Q4 		$233K Buy
+2,522
New +$222K 0.14% 235

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Quantamental Technologies's ABBV Position: Q3 2023 in Review

Quantamental Technologies sold out of AbbVie (ABBV) in Q3 2023, closing a stake of 10,352 shares — an estimated $1.39M sold.

Quantamental Technologies first reported a position in ABBV in Q4 2018 and held it in 4 quarters. The position peaked at $1.39M in Q2 2023. 3,109 funds tracked by Wall St. Rank hold ABBV as of Q3 2023.

  • Quantamental Technologies reported no remaining AbbVie position as of Q3 2023 after selling out during the quarter.
  • Quantamental Technologies sold 10,352 AbbVie shares in Q3 2023, an estimated $1.39M.
  • Quantamental Technologies first reported a position in AbbVie in Q4 2018 and held it in 4 quarters.
  • Quantamental Technologies's AbbVie position peaked at $1.39M in Q2 2023.
  • 3,109 funds tracked by Wall St. Rank held AbbVie as of Q3 2023.

Based on Quantamental Technologies's 13F filing for Q3 2023, filed 14 Nov 2023.